Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
AMPLIFY and fixed‑duration BTK strategies
Rogers summarizes AMPLIFY results showing AV/AVO superiority over chemoimmunotherapy and infection risks with anti‑CD20.
Play episode from 06:04
Transcript
